EMILY KIM, MD
Psychiatric at Hammond St, Boston, MA
License number
Massachusetts 74159
Category
Psychiatric
Type
Psychiatry
Address
Address
828 Hammond St, Boston, MA 02467
Phone
(617) 232-1199
Personal information
See more information about EMILY KIM at radaris.comName
Address
Phone
21 Fthr Frncs Glday St Apt 207, Boston, MA 02118
630 Hammond St #209, Chestnut Hill, MA 02467
20 Webster St, Brookline, MA 02446
110 Commonwealth Ave, Chestnut Hill, MA 02467
Organization information
See more information about EMILY KIM at bizstanding.comEmily Kim MD
21 Father Francis Gilday St APT 207, Boston, MA 02118
Industry:
Psychiatrist
Phone:
(617) 232-1199 (Phone)
Emily Eun-Me Kim
Professional information
Dr. Emily Kim, Chestnut Hill MA - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Psychiatry)
Address:
828 Hammond St, Chestnut Hill 02467
(617) 232-1199 (Phone)
(617) 232-1199 (Phone)
Certifications:
Psychiatry, 1994
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of North Carolina At Chapel Hill
Graduated: 1988
University of North Carolina At Chapel Hill
Graduated: 1988
Cell Death Protein
US Patent:
5674734, Oct 7, 1997
Filed:
May 18, 1995
Appl. No.:
8/444005
Inventors:
Philip Leder - Chestnut Hill MA
Brian Seed - Boston MA
Ben Z. Stanger - Brookline MA
Tae-Ho Lee - Daejeon, KR
Emily Kim - Chestnut Hill MA
Brian Seed - Boston MA
Ben Z. Stanger - Brookline MA
Tae-Ho Lee - Daejeon, KR
Emily Kim - Chestnut Hill MA
Assignee:
President and Fellows of Harvard College - Cambridge MA
The General Hospital Corporation - Boston MA
The General Hospital Corporation - Boston MA
International Classification:
C12N 120, C07H 2102, C07H 2104, C12P 2106
US Classification:
4352523
Abstract:
Disclosed is a protein, designated RIP, which contains a death domain at its carboxy terminus and a kinase domain at its amino terminus. RIP interacts with the Fas/APO-1 intracellular domain and the TNFR1 intracellular domain. When expressed in transformed host cells, recombinant RIP promotes apoptosis. Also disclosed are DNA molecules encoding RIP, anti-RIP antibodies, and screening methods for discovering inhibitors of RIP-dependent apoptosis.